Alto Neuroscience, Inc. Common Stock (ANRO)

Operating Expenses

-$44.64M

TTM · Period ending: · USD

ANRO logo

ANRO Operating Expenses

Latest reported-$44.64M
ANRO TTM Operating Expenses ($33.82M → -$44.64M)
High-resolution chart · PNG

ANRO operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Alto Neuroscience, Inc. Common Stock Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
-44,639,000
-55,186,000
-66,464,000
66,036,000
69,971,000
69,730,000
68,343,000
63,189,000
54,021,000
44,705,000
37,531,000
33,821,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.